Coughlin Stoia Geller Rudman & Robbins LLP Files Cla
Action Suit against Stryker Corporation
January 15, 2010 05:45 PM Eastern Time
NEW YORK--(EON: Enhanced Online News)--Coughlin Stoia Geller Rudman & Robbins LLP (“Coughlin Stoia”)
(http://www.csgrr.com/cases/stryker/) today announced that a class action has been commenced on behalf of an institutional investo
States District Court for the Southern District of New York on behalf of purchasers of the common stock of Stryker Corporation (“
“Company”) (NYSE:SYK) between January 25, 2007 and November 13, 2008, inclusive (the “Class Period”), seeking to pursue
Securities Exchange Act of 1934 (the “Exchange Act”).
If you wish to serve as lead plaintiff, you must move the Court no later than 60 days from today. If you wish to discuss this action or
questions concerning this notice or your rights or interests, please contact plaintiff’s counsel, Samuel H. Rudman or David A. Rosen
Stoia at 800/449-4900 or 619/231-1058, or via e-mail at firstname.lastname@example.org. If you are a member of this Class, you can view a copy
as filed or join this class action online at http://www.csgrr.com/cases/stryker/. Any member of the putative class may move the Cour
plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member.
The complaint charges Stryker and certain of its officers and executives with violations of the Exchange Act. Stryker is a medical te
company. Stryker manufactures and sells medical devices, primarily orthopedic surgical implants, and medical equipment.
The complaint alleges that, throughout the Class Period, defendants failed to disclose material adverse facts about the Company’s tr
condition, business and prospects. Specifically, the complaint alleges that defendants: i) violated federal regulations regarding the ma
medical devices; ii) subjected the Company to unnecessary risks of sales disruptions, lower revenues and product liabilities due to p
iii) hid hundreds of millions of dollars of additional compliance c